col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer Science and Business Media LLC: Cell Discovery
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―07 RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates Xiaoyan Pan, Jian Shi, Xue Hu, Yan Wu, Liang Zeng, Yanfeng Yao, et al. (+25)
2 [GO] 2021―Aug―31 Genome-wide association study of COVID-19 severity among the Chinese population Yuanfeng Li, Yuehua Ke, Xinyi Xia, Yahui Wang, Fanjun Cheng, Xinyi Liu, et al. (+21)
3 [GO] 2021―Aug―24 Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells Huabin Ma, Zhoujie Zhu, Huaipeng Lin, Shanshan Wang, Peipei Zhang, Yanguo Li, et al. (+4)
4 [GO] 2021―Aug―18 Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection Jinkai Zang, Yuanfei Zhu, Yu Zhou, Chenjian Gu, Yufang Yi, Shuxia Wang, et al. (+13)
5 [GO] 2021―Aug―17 Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein Wenjie Huang, Xiaohui Ju, Min Tian, Xiaoyu Li, Yanying Yu, Qingxiang Sun, et al. (+2)
6 [GO] 2021―Aug―17 Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy Ming-Liang Ma, Da-Wei Shi, Yang Li, Wei Hong, Dan-Yun Lai, Jun-Biao Xue, et al. (+20)
7 [GO] 2021―Aug―17 Establishment of a humanized swine model for COVID-19 Xuguang Du, Zihang Guo, Wenhui Fan, Tang Hai, Fei Gao, Pan Li, et al. (+9)
8 [GO] 2021―Aug―17 Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine Pai Peng, Hai-jun Deng, Jie Hu, Xiao-yu Wei, Jian-jiang Xue, Ting-ting Li, et al. (+10)
9 [GO] 2021―Aug―12 Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo Zhaoyong Zhang, Eric Zeng, Lu Zhang, Weiming Wang, Yingkang Jin, Jiye Sun, et al. (+21)
10 [GO] 2021―Aug―04 Dysregulated hematopoiesis in bone marrow marks severe COVID-19 Xin Wang, Yanling Wen, Xiaowei Xie, Yang Liu, Xiaohua Tan, Qingxian Cai, et al. (+16)
11 [GO] 2021―Jul―27 ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers Furong Qi, Gang Xu, Xuejiao Liao, Fuxiang Wang, Jing Yuan, Haiyan Wang, et al. (+4)
12 [GO] 2021―Jul―27 Author Correction: Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication Wen Juan Tu, Robert D. McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, et al. (+13)
13 [GO] 2021―Jul―27 Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries Yongbing Pan, Jianhui Du, Jia Liu, Hai Wu, Fang Gui, Nan Zhang, et al. (+18)
14 [GO] 2021―Jul―20 Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants Jianhui Nie, Jingshu Xie, Shuo Liu, Jiajing Wu, Chuan Liu, Jianhui Li, et al. (+11)
15 [GO] 2021―Jul―20 hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants Junli Liu, Qi Chen, Shumin Yang, Ying Li, Yang Dou, Yong-Qiang Deng, et al. (+10)
16 [GO] 2021―Jul―06 A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease Zheng Fu, Jian Wang, Zheng Wang, Ying Sun, Jian Wu, Yongchen Zhang, et al. (+8)
17 [GO] 2021―Jul―06 SARS-CoV-2 infection in the mouse olfactory system Qing Ye, Jia Zhou, Qi He, Rui-Ting Li, Guan Yang, Yao Zhang, et al. (+13)
18 [GO] 2021―Jun―15 Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2 Jingsong Zhang, Yang Zhang, Jun-Yan Kang, Shuiye Chen, Yongqun He, Benhao Han, et al. (+5)
19 [GO] 2021―Jun―08 Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19 Yun Tan, Wei Zhang, Zhaoqin Zhu, Niu Qiao, Yun Ling, Mingquan Guo, et al. (+22)
20 [GO] 2021―May―25 SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication Zhou-Qin Zheng, Su-Yun Wang, Zhi-Sheng Xu, Yu-Zhi Fu, Yan-Yi Wang
21 [GO] 2021―May―24 Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication Wen Juan Tu, Robert D. McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, et al. (+13)
22 [GO] 2021―May―04 The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes Yabin Zhang, Hao Sun, Rongjuan Pei, Binli Mao, Zhenyu Zhao, Huihui Li, et al. (+2)
23 [GO] 2021―May―03 Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, et al. (+10)
24 [GO] 2021―Apr―13 Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients Huanzi Zhong, Yanqun Wang, Zhun Shi, Lu Zhang, Huahui Ren, Weiqun He, et al. (+27)
25 [GO] 2021―Apr―13 Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages Jiadi Lv, Zhenfeng Wang, Yajin Qu, Hua Zhu, Qiangqiang Zhu, Wei Tong, et al. (+12)
26 [GO] 2021―Apr―06 Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses Jianhui Nie, Qianqian Li, Li Zhang, Yang Cao, Yue Zhang, Tao Li, et al. (+18)
27 [GO] 2021―Mar―30 Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs Bo Lu, Yi Yan, Liting Dong, Lingling Han, Yawei Liu, Junping Yu, et al. (+10)
28 [GO] 2021―Mar―25 Immune memory in convalescent patients with asymptomatic or mild COVID-19 Quan-Xin Long, Yan-Jun Jia, Xin Wang, Hai-Jun Deng, Xiao-Xia Cao, Jun Yuan, et al. (+15)
29 [GO] 2021―Mar―23 SARS-CoV-2 cell tropism and multiorgan infection Jia Liu, Yufeng Li, Qian Liu, Qun Yao, Xi Wang, Huanyu Zhang, et al. (+9)
30 [GO] 2021―Jan―28 N6-methyladenosine regulates RNA abundance of SARS-CoV-2 Ting Zhang, Ying Yang, Zichun Xiang, Chun-Chun Gao, Wenjing Wang, Conghui Wang, et al. (+10)
31 [GO] 2021―Jan―21 SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region Jia Wang, Chengrui Shi, Qun Xu, Hang Yin
32 [GO] 2020―Dec―22 Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, et al. (+10)
33 [GO] 2020―Nov―13 Infection of human sweat glands by SARS-CoV-2 Jia Liu, Yufeng Li, Liang Liu, Xudong Hu, Xi Wang, Hengrui Hu, et al. (+3)
34 [GO] 2020―Nov―10 Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility Fang Wang, Shujia Huang, Rongsui Gao, Yuwen Zhou, Changxiang Lai, Zhichao Li, et al. (+21)
35 [GO] 2020―Nov―04 Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro Qi Zhang, Catherine Zhengzheng Chen, Manju Swaroop, Miao Xu, Lihui Wang, Juhyung Lee, et al. (+11)
36 [GO] 2020―Oct―29 Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients Feifei Yan, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Jingjun Lv, et al. (+11)
37 [GO] 2020―Oct―29 Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Chen, Minghui Cheng, et al. (+13)
38 [GO] 2020―Oct―27 Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays Ying Tian, Chaoyang Lian, Yingying Chen, Dong Wei, Xinxin Zhang, Yun Ling, et al. (+2)
39 [GO] 2020―Oct―20 The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing Gang Xu, Furong Qi, Hanjie Li, Qianting Yang, Haiyan Wang, Xin Wang, et al. (+7)
40 [GO] 2020―Oct―13 Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation Pei-Gang Wang, Dong-Jiang Tang, Zhan Hua, Zai Wang, Jing An
41 [GO] 2020―Sep―30 Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2 Lili Wu, Qian Chen, Kefang Liu, Jia Wang, Pengcheng Han, Yanfang Zhang, et al. (+13)
42 [GO] 2020―Sep―15 Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019 Min Huang, Qing-Bin Lu, Han Zhao, Yulan Zhang, Zhiwei Sui, Liqun Fang, et al. (+5)
43 [GO] 2020―Sep―15 SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2 Jingfang Mu, Yaohui Fang, Qi Yang, Ting Shu, An Wang, Muhan Huang, et al. (+4)
44 [GO] 2020―Sep―11 Decreased HD-MIR2911 absorption in human subjects with the SIDT1 polymorphism fails to inhibit SARS-CoV-2 replication Zhen Zhou, Yu Zhou, Xia-Ming Jiang, Yanbo Wang, Xi Chen, Gengfu Xiao, et al. (+4)
45 [GO] 2020―Sep―03 Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement Jinkai Zang, Chenjian Gu, Bingjie Zhou, Chao Zhang, Yong Yang, Shiqi Xu, et al. (+9)
46 [GO] 2020―Aug―13 Survival of SARS-COV-2 under liquid medium, dry filter paper and acidic conditions Zhiping Sun, Xia Cai, Chenjian Gu, Rong Zhang, Wendong Han, Yun Qian, et al. (+7)
47 [GO] 2020―Aug―05 Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients Li-Kun Zhou, Zhen Zhou, Xia-Ming Jiang, Yishan Zheng, Xi Chen, Zheng Fu, et al. (+4)
48 [GO] 2020―Jul―24 Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro Paul S. Kwon, Hanseul Oh, Seok-Joon Kwon, Weihua Jin, Fuming Zhang, Keith Fraser, et al. (+3)
49 [GO] 2020―Jun―19 Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, et al. (+12)
50 [GO] 2020―May―27 Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA Simin Xia, Xi Chen
51 [GO] 2020―May―18 SARS-CoV-2 detection with CRISPR diagnostics Lu Guo, Xuehan Sun, Xinge Wang, Chen Liang, Haiping Jiang, Qingqin Gao, et al. (+10)
52 [GO] 2020―May―04 Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, et al. (+12)
53 [GO] 2020―May―02 The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro Xi Wang, Ruiyuan Cao, Huanyu Zhang, Jia Liu, Mingyue Xu, Hengrui Hu, et al. (+10)
54 [GO] 2020―Mar―18 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, et al. (+4)
55 [GO] 2020―Mar―16 Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Yadi Zhou, Yuan Hou, Jiayu Shen, Yin Huang, William Martin, Feixiong Cheng
56 [GO] 2020―Feb―24 Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations Yanan Cao, Lin Li, Zhimin Feng, Shengqing Wan, Peide Huang, Xiaohui Sun, et al. (+4)
57 [GO] 2020―Feb―24 Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China Huwen Wang, Zezhou Wang, Yinqiao Dong, Ruijie Chang, Chen Xu, Xiaoyue Yu, et al. (+9)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec